These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 27091765)

  • 21. Effects of treatment with chenodeoxycholic acid on liver microsomal metabolism of steroids in man.
    Ahlberg J; Angelin B; Björkhem I; Einarsson K; Gustafsson JA; Rafter J
    J Lab Clin Med; 1980 Feb; 95(2):188-94. PubMed ID: 6766490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epimerization of chenodeoxycholic acid to ursodeoxycholic acid by Clostridium baratii isolated from human feces.
    Lepercq P; Gérard P; Béguet F; Raibaud P; Grill JP; Relano P; Cayuela C; Juste C
    FEMS Microbiol Lett; 2004 Jun; 235(1):65-72. PubMed ID: 15158263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in 3β-hydroxysteroid dehydrogenase activity and in pregnenolone supply rate can paradoxically alter androstenedione synthesis.
    Nguyen PT; Lee RS; Conley AJ; Sneyd J; Soboleva TK
    J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):12-20. PubMed ID: 22024430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tauroursodeoxycholic acid. Chemicol-physical profile].
    Bozzo Costa E; Schiano I; Bisegna F; Parenti M
    Boll Chim Farm; 1987 Oct; 126(10):417-23. PubMed ID: 3453733
    [No Abstract]   [Full Text] [Related]  

  • 25. Obeticholic Acid: First Global Approval.
    Markham A; Keam SJ
    Drugs; 2016 Aug; 76(12):1221-6. PubMed ID: 27406083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver.
    Stiehl A; Ast E; Czygan P; Fröhling W; Raedsch R; Kommerell B
    Gastroenterology; 1978 Mar; 74(3):572-7. PubMed ID: 631488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obeticholic acid: a new light in the shadows treating portal hypertension?
    Gracia-Sancho J; Hernández-Gea V; Garcia-Pagán JC
    Hepatology; 2014 Jun; 59(6):2072-3. PubMed ID: 24452422
    [No Abstract]   [Full Text] [Related]  

  • 29. Transformation of chenodeoxycholic acid by thermophilic Geobacillus stearothermophilus.
    Afzal M; Oommen S; Al-Awadi S
    Biotechnol Appl Biochem; 2011; 58(4):250-5. PubMed ID: 21838799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new drug carrier, Nalpha-deoxycholyl-L: -lysyl-methylester, for enhancing insulin absorption in the intestine.
    Lee S; Lee J; Lee DY; Kim SK; Lee Y; Byun Y
    Diabetologia; 2005 Mar; 48(3):405-11. PubMed ID: 15739118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.
    Pellicciari R; Costantino G; Camaioni E; Sadeghpour BM; Entrena A; Willson TM; Fiorucci S; Clerici C; Gioiello A
    J Med Chem; 2004 Aug; 47(18):4559-69. PubMed ID: 15317466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reply: To PMID 24259407.
    Verbeke L; Trebicka J; Laleman W
    Hepatology; 2014 Nov; 60(5):1799-800. PubMed ID: 24623183
    [No Abstract]   [Full Text] [Related]  

  • 35. [Not Available].
    Pariente A
    Rev Prat; 2015 Feb; 65(2):171. PubMed ID: 25939215
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of tauroursodeoxycholic acid on patients with ileal resection.
    Peled Y; Bar-Meir S; Rotmensch HH; Tiomny A; Gilat T
    Isr J Med Sci; 1982 Jul; 18(7):812-4. PubMed ID: 7107225
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preliminary observations on the therapeutic use of tauroursodeoxycholate].
    Belvisi A; Magnanelli M; Matergi M; Camarri E
    Clin Ter; 1986 Jun; 117(6):475-9. PubMed ID: 3742969
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple and general strategy for the design of fluorescent cation sensor beads.
    Nath S; Maitra U
    Org Lett; 2006 Jul; 8(15):3239-42. PubMed ID: 16836375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proceedings: Elevation of transaminases following treatment with chenodeoxycholic acid: dependence on chenodeoxycholic acid dosage and on serum chenodeoxycholic acid concentration].
    Stiehl A; Regula M; Kommerell B
    MMW Munch Med Wochenschr; 1975 May; 117(20):840. PubMed ID: 805967
    [No Abstract]   [Full Text] [Related]  

  • 40. Chenodeoxycholic acid administration monitored by serum bile acid profiles: a dose-response study.
    Whiting MJ; Down RH; Watts JM
    Ann Clin Biochem; 1983 Nov; 20 (Pt 6)():336-40. PubMed ID: 6651198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.